National survey of China's oncologists' knowledge, attitudes, and clinical practice patterns on complementary and alternative medicine

Oncotarget

Volumn 8, Issue 8, 2017, Pages 13440-13449

  Yang, Geliang ^a   Lee, Richard ^b   Zhang, Huiqing ^a   Gu, Wei ^a   Yang, Peiying ^c   Ling, Changquan ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF TEXAS   (United States)

Author keywords

Attitudes; Complementary and alternative medicine; Knowledge; National survey; Oncologists

Indexed keywords

ADULT; ALTERNATIVE MEDICINE; CANCER THERAPY; CHINA; CHINESE MEDICINE; CLINICAL PRACTICE; DOCTOR PATIENT RELATION; HUMAN; LICENCE; MAJOR CLINICAL STUDY; MALE; ONCOLOGIST; SYMPTOM; VOCATIONAL EDUCATION; ATTITUDE TO HEALTH; FEMALE; MIDDLE AGED; NEOPLASMS; ONCOLOGY; PHYSICIAN; QUESTIONNAIRE;

ADULT; CHINA; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; MALE; MEDICAL ONCOLOGY; MEDICINE, CHINESE TRADITIONAL; MIDDLE AGED; NEOPLASMS; PHYSICIANS; SURVEYS AND QUESTIONNAIRES;

EID: 85013499710     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.14560     Document Type: Article

References (28)

1. Chen W, Zheng R, Baade PD, Zhang S, Zeng H, Bray F, Jemal A, Yu XQ, He J. Cancer statistics in China, 2015. CA Cancer J Clin. 2016. doi: 10.3322/caac.21338
2. Astin JA. Why patients use alternative medicine: results of a national study. JAMA. 1998; 279:1548-53
3. Boon H, Stewart M, Kennard MA, Gray R, Sawka C, Brown JB, McWilliam C, Gavin A, Baron RA, Aaron D. Use of complementary/alternative medicine by breast cancer survivors in Ontario: prevalence and perceptions. J Clin Oncol. 2000; 18:2515-21
4. Barnes PM, Bloom B, Nahin RL. Complementary and alternative medicine use among adults and children: United States, 2007. Hyattsville, MD, National Center for Health Statistics, No. 1-18, 2008
5. Richardson MA, Masse LC, Nanny K, Sanders C. Discrepant views of oncologists and cancer patients on complementary/alternative medicine. Support Care Cancer. 2004; 12:797-804. doi: 10.1007/s00520-004-0677-3
6. Chang KH, Brodie R, Choong MA, Sweeney KJ, Kerin MJ. Complementary and alternative medicine use in oncology: A questionnaire survey of patients and health care professionals. BMC Cancer. 2011; 11. doi: Artn 196 Doi 10.1186/1471-2407-11-196
7. Kim do Y, Kim BS, Lee KH, Lee MA, Hong YS, Shin SW, Lee SN. Discrepant views of Korean medical oncologists and cancer patients on complementary and alternative medicine. Cancer Res Treat. 2008; 40:87-92. doi: 10.4143/crt.2008.40.2.87
8. Risberg T, Kolstad A, Bremnes Y, Holte H, Wist EA, Mella O, Klepp O, Wilsgaard T, Cassileth BR. Knowledge of and attitudes toward complementary and alternative therapies; a national multicentre study of oncology professionals in Norway. Eur J of Cancer. 2004; 40:529-35. doi: 10.1016/j.ejca.2003.11.011S0959804903010165 [pii]
9. Hyodo I, Eguchi K, Nishina T, Endo H, Tanimizu M, Mikami I, Takashima S, Imanishi J. Perceptions and attitudes of clinical oncologists on complementary and alternative medicine: a nationwide survey in Japan. Cancer. 2003; 97:2861-8. doi: 10.1002/cncr.11402
10. Lee RT, Barbo A, Lopez G, Melhem-Bertrandt A, Lin H, Olopade OI, Curlin FA. National survey of US oncologists' knowledge, attitudes, and practice patterns regarding herb and supplement use by patients with cancer. J Clin Oncol. 2014; 32:4095-101. doi: JCO.2014.55.8676 [pii]10.1200/JCO.2014.55.8676
11. Sparreboom A, Cox MC, Acharya MR, Figg WD. Herbal remedies in the United States: potential adverse interactions with anticancer agents. J Clin Oncol. 2004; 22:2489-503. doi: 10.1200/JCO.2004.08.182
12. McCune JS, Hatfield AJ, Blackburn AA, Leith PO, Livingston RB, Ellis GK. Potential of chemotherapy-herb interactions in adult cancer patients. Support Care Cancer. 2004; 12:454-62. doi: 10.1007/s00520-004-0598-1
13. Golden EB, Lam PY, Kardosh A, Gaffney KJ, Cadenas E, Louie SG, Petasis NA, Chen TC, Schönthal AH. Green tea polyphenols block the anticancer effects of bortezomib and other boronic acid-based proteasome inhibitors. Blood. 2009; 113:5927-37. doi: 10.1182/blood-2008-07-171389
14. Andersen MR, Sweet E, Lowe KA, Standish LJ, Drescher CW, Goff BA. Dangerous combinations: ingestible CAM supplement use during chemotherapy in patients with ovarian cancer. J Altern Complement Med. 2013; 19:714-20. doi: 10.1089/acm.2012.0295
15. Ling CQ, Wang LN, Wang Y, Zhang YH, Yin ZF, Wang M, Ling C. The roles of traditional Chinese medicine in gene therapy. J Integr Med. 2014; 12:67-75. doi: 10.1016/S2095-4964(14)60019-4
16. Ji Q, Luo YQ, Wang WH, Liu X, Li Q, Su SB. Research advances in traditional Chinese medicine syndromes in cancer patients. J Integr Med. 2016; 14:12-21. doi: 10.1016/S2095-4964(16)60237-6
17. Patterson RE, Neuhouser ML, Hedderson MM, Schwartz SM, Standish LJ, Bowen DJ, Marshall LM. Types of alternative medicine used by patients with breast, colon, or prostate cancer: predictors, motives, and costs. J Altern Complement Med. 2002; 8:477-85
18. Morris KT, Johnson N, Homer L, Walts D. A comparison of complementary therapy use between breast cancer patients and patients with other primary tumor sites. Am J Surg. 2000; 179:407-11
19. Hyodo I, Amano N, Eguchi K, Narabayashi M, Imanishi J, Hirai M, Nakano T, Takashima S. Nationwide survey on complementary and alternative medicine in cancer patients in Japan. J Clin Oncol. 2005; 23:2645-54
20. Statistical Information Center of Ministry of Health of China: China's Health Statistics of 2015. Beijing, China, China Union Medical University Press. 2015;pp13-98
21. Lee RT, Hlubocky FJ, Hu JJ, Stafford RS, Daugherty CK. An international pilot study of oncology physicians' opinions and practices on Complementary and Alternative Medicine (CAM). Integr Cancer Ther. 2008; 7:70-5. doi: 10.1177/1534735408319059
22. Rhode JM, Patel DA, Sen A, Schimp VL, Johnston CM, Liu JR. Perception and use of complementary and alternative medicine among gynecologic oncology care providers. Int J Gynecol Obstet. 2008; 103:111-5. doi: 10.1016/j.ijgo.2008.06.001
23. Roth M, Lin J, Kim M, Moody K. Pediatric Oncologists' Views Toward the Use of Complementary and Alternative Medicine in Children With Cancer. J Pediat Hematol Onc. 2009; 31:177-82. doi: 10.1097/MPH.0b013e3181984f5a
24. Samano E, Ribeiro L, Campos A, Lewin F, Goldenstein P, COSTA L, del Giglio A. Use of complementary and alternative medicine by Brazilian oncologists. Eur J Cancer Care. 2005; 14:143-8
25. McQuade JL, Meng Z, Chen Z, Wei Q, Zhang Y, Bei W, Palmer JL and Cohen L. Utilization of and attitudes towards traditional Chinese medicine therapies in a Chinese cancer hospital: a survey of patients and physicians. Evid-Based Compl Alt. 2012; 2012:504507. doi: 10.1155/2012/504507
26. Hlubocky FJ, Ratain MJ, Wen M and Daugherty CK. Complementary and alternative medicine among advanced cancer patients enrolled on phase I trials: A study of prognosis, quality of life, and preferences for decision making. J Clin Oncol. 2007; 25:548-554
27. Cheng CW, Fan W, Ko SG, Song L, Bian ZX. Evidencebased management of herb-drug interaction in cancer chemotherapy. Explore (NY). 2010; 6:324-9. doi: S1550-8307(10)00129-1 [pii]10.1016/j.explore.2010.06.004
28. Ernst E. Exploring the Science of Complementary and Alternative Medicine: Third Strategic Plan, 2011-2015. Focus on Alternative and Complementary Therapies. 2012; 17:e7